NTRS proposes sale of 2,800 common shares

NTRS reports a proposed sale under Form 144 of 2,800 shares of Common Stock with an aggregate amount of $462,058.80, reflected on 04/24/2026.

Rhea-AI Filing Summary

NTRS reports a proposed sale under Form 144 of 2,800 shares of Common Stock with an aggregate amount of $462,058.80, reflected on 04/24/2026. The filing also lists a prior sale by Clive A. Bellows of 1,148 shares on 02/12/2026 for $166,752.74, and notes a restricted stock vesting event on 03/01/2026 for 2,800 shares issued as compensation.

Insights

Insider Transactions Analyst

Form 144 shows a proposed resale of 2,800 common shares and a recent insider sale of 1,148 shares.

The filing lists a proposed disposition of 2,800 shares with an aggregate value of $462,058.80 and records a prior sale by Clive A. Bellows of 1,148 shares for $166,752.74. The entry for Restricted Stock Vesting on 03/01/2026 indicates 2,800 shares were issued as compensation.

Cash‑flow treatment and the identity of the selling holder for the proposed sale are implied by the Form 144 fields; the filing does not provide further sale mechanics or timing beyond the stated dates. Subsequent filings or broker reports would show execution details.

Key Figures

Proposed shares to be sold: 2,800 shares Aggregate amount for proposed sale: $462,058.80 Shares sold in prior 3 months: 1,148 shares +2 more

5 metrics

Proposed shares to be sold 2,800 shares Form 144 entry dated <date>04/24/2026</date>

Aggregate amount for proposed sale $462,058.80 Aggregate value listed with the 2,800 shares on <date>04/24/2026</date>

Shares sold in prior 3 months 1,148 shares Sale by Clive A. Bellows on <date>02/12/2026</date>

Proceeds from prior sale $166,752.74 Amount reported for 1,148-share sale on <date>02/12/2026</date>

Restricted stock vesting 2,800 shares Vesting/compensation event on <date>03/01/2026</date>

Key Terms

Form 144, Restricted Stock Vesting, Aggregate offering amount

3 terms

Form 144 regulatory

"Proposed sale of securities under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer | 2800 | 03/01/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Aggregate offering amount financial

"2800 | 462058.80 listed alongside the securities to be sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does NTRS's Form 144 disclose about shares being sold?

The filing discloses a proposed sale of 2,800 shares of Common Stock valued at $462,058.80 with a filing date of 04/24/2026. It records the amount and aggregate value but does not list execution details or sale timing.

Did any insider recently sell NTRS shares?

Yes. The filing lists Clive A. Bellows as selling 1,148 shares on 02/12/2026 for $166,752.74. This sale appears in the "Securities Sold During The Past 3 Months" section of the Form 144 excerpt.

What is the significance of the "Restricted Stock Vesting" entry?

The entry shows 2,800 shares were issued upon restricted stock vesting on 03/01/2026 as compensation. It documents grant/issuance activity but does not itself indicate any sale or transfer timing.

Does the Form 144 state who will receive proceeds from the proposed sale?

The excerpt lists the disposition and aggregate amount $462,058.80 but does not specify who will receive proceeds. The filing fields identify the shares and proposed sale value without describing recipient allocation or use.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/24/2026 - 12:43 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002027224
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NORTHERN TRUST CORP
SEC File Number	001-36609
Address of Issuer	50 S LASALLE ST CHICAGO ILLINOIS 60603
Phone	3126306000
Name of Person for Whose Account the Securities are To Be Sold	Bellows Clive
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2800	462058.80	185827803	04/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2026	Restricted Stock Vesting	Issuer			2800	03/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Clive A Bellows 50 South La Salle Street Chicago IL 60603	Common	02/12/2026	1148	166752.74

144: Remarks and Signature

Remarks
Date of Notice	04/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Clive Bellows
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)